The improved loss profile and balance sheet strengthening are positive, but worsening adjusted EBITDA and heavy dilution (shares outstanding surged from ~2,500 to ~1.8M) cap the upside.
Price Chart
Executive Summary
INVO Fertility reported FY2025 revenue of $6.84M (+5% YoY) and a net loss from continuing operations of $(5.3)M, improving from $(7.7)M in FY2024. The company highlighted a strengthened balance sheet after $11.5M in financing, the acquisition of Family Beginnings, and conversion of all Series C-2 Preferred Stock, but adjusted EBITDA worsened to $(3.2)M from $(2.2)M. Despite operational progress, the stock remains highly speculative with a $2M market cap and negative historical returns on prior calls.
Key Financial Metrics
Key Facts
- FY2025 revenue $6.84M, +5% YoY from $6.53M
- Net loss from continuing operations improved to $(5.3)M from $(7.7)M
- Adjusted EBITDA worsened to $(3.2)M from $(2.2)M
- Completed $11.5M in financing (Dec 2025/Jan 2026) and acquired Family Beginnings clinic
- All Series C-2 Preferred Stock converted or retired; common shares outstanding ~1.8M as of June 2, 2026
- EPS from continuing operations: $(45.57) basic/diluted (FY2025) vs $(3,078.74) in FY2024 (driven by massive share count increase from 2,514 to 117,083 weighted avg shares)
Financial Impact
Revenue growth of ~$309K (+5%) YoY; net loss improved by ~$2.4M; adjusted EBITDA declined by ~$925K; EPS improved from $(3,078.74) to $(45.57) due to share dilution
Risk Factors
- Adjusted EBITDA deterioration despite revenue growth
- Massive share dilution (weighted avg shares from 2,514 to 117,083) obscures true per-share improvement
- Micro-cap ($2M market cap) with low liquidity and negative historical returns on prior analyst calls
- Reliance on continued financing and acquisition pipeline for growth
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3305182 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | SC 13G/A | $0.7275 $0.5576 | ▲ +23.35% | ▲ +21.39% | $0.5718 (+21.40%) |
Aug 28, 2026 8w ago | 8-K | $1.00 $0.9850 | ▲ +1.50% | ▲ +1.61% | $0.5718 (+42.82%) |
Aug 17, 2026 10w ago | 8-K | $1.53 $1.03 | ▼ −32.68% | ▼ −31.49% | $0.5718 (−62.63%) |
Aug 17, 2026 10w ago | Press Release | $1.53 $1.03 | ▲ +32.68% | ▲ +31.49% | $0.5718 (+62.63%) |
Aug 5, 2026 11w ago | EFFECT | $1.08 $1.01 | ▲ +6.05% | ▲ +6.40% | $0.5718 (+46.81%) |
Jun 25, 2026 17w ago | 8-K | $2.45 $1.62 | ▼ −33.88% | ▼ −36.04% | $0.5718 (−76.66%) |
Jun 22, 2026 18w ago | Press Release | $1.39 $2.45 | ▼ −76.26% | ▼ −78.33% | $0.5718 (+58.86%) |
Jun 16, 2026 18w ago | 8-K | $1.59 $1.32 | ▼ −16.98% | ▼ −15.94% | $0.5718 (−64.04%) |
Jun 2, 2026 20w ago | Press Release | $1.70 $1.41 | ▲ +17.06% | ▲ +13.24% | $0.5718 (+66.36%) |
Jun 2, 2026 21w ago | 8-K | $1.52 $1.40 | ▼ −7.89% | ▼ −4.93% | $0.5718 (−62.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers